Related Experiment Video
Updated: Aug 27, 2025
Author Spotlight: Extraction of Guinea Pig Round Window Membrane to Facilitate Inner Ear Drug Delivery Research
Published on: February 23, 2024
An Evaluation of the Drug Permeability Properties of Human Cadaveric In Situ Tympanic and Round Window Membranes
Joachim G S Veit1,2, Bhaskar Birru1,2, Yong Wang3
1Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, USA.
Abstract:
It is estimated that hearing loss currently affects more than 1.5 billion people, or approximately 20% of the global population; however, presently, there are no Food and Drug Administration-approved therapeutics or prophylactics for this condition. While continued research on the development of otoprotective drugs to target this clear unmet need is an obvious path, there are numerous challenges to translating promising therapeutic candidates into human clinical testing. The screening of promising drug candidates relies exclusively on preclinical models. Current models do not permit the rapid high-throughput screening of promising drug candidates, and their relevance to clinical scenarios is often ambiguous. With the current study, we seek to understand the drug permeability properties of the cadaveric tympanic and round window membranes with the goal of generating knowledge that could inform the design and/or evaluation of in vitro organotypic models. The development of such models could enable the early high-throughput screening of topical therapeutic candidates and should address some of the limitations of currently used animal models.
Insights
This study investigates drug permeability through human ear membranes to improve hearing loss treatments. Findings will help develop new in vitro models for faster drug screening, addressing a critical need for effective therapies.
Area of Science:
- Otolaryngology
- Drug Delivery
- Regenerative Medicine
Background:
- Hearing loss affects over 1.5 billion people globally, with no FDA-approved treatments.
- Current preclinical models for drug screening are slow and lack clinical relevance.
- There is a significant unmet need for effective otoprotective drugs and efficient screening methods.
Purpose of the Study:
- To investigate drug permeability across cadaveric tympanic and round window membranes.
- To gather data for designing and evaluating novel in vitro organotypic models.
- To overcome limitations of current animal models in preclinical drug testing.
Main Methods:
- Utilized cadaveric human tympanic and round window membranes.
- Assessed drug permeability properties through these biological barriers.
- Focused on understanding transport mechanisms relevant to topical drug delivery.
Main Results:
- Characterized drug permeability profiles of the tympanic and round window membranes.
- Generated foundational data for the development of in vitro drug screening models.
- Identified key parameters influencing drug passage through these membranes.
Conclusions:
- Understanding membrane permeability is crucial for developing effective in vitro models.
- Novel organotypic models can enable high-throughput screening of topical therapeutics.
- This research paves the way for accelerated development of hearing loss treatments.
More Related Videos
09:18A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
Published on: March 8, 2017
12:21The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Related Concept Videos
01:16Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
01:16Anatomy of the Ear
01:09Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...